Systemic Inflammation Rapidly Induces Reversible Atrial Electrical Remodeling: The Role of Interleukin-6-Mediated Changes in Connexin Expression.
Adult
Aged
Aged, 80 and over
Animals
Anti-Bacterial Agents
/ therapeutic use
Anti-Inflammatory Agents
/ therapeutic use
Arthritis, Rheumatoid
/ drug therapy
Atrial Remodeling
/ genetics
C-Reactive Protein
/ immunology
Cardiac Surgical Procedures
Connexin 43
/ drug effects
Connexins
/ drug effects
Electrocardiography
Female
Gene Expression Regulation
Heart Atria
/ cytology
Humans
Infections
/ drug therapy
Inflammation
/ drug therapy
Interleukin-1
/ immunology
Interleukin-10
/ immunology
Interleukin-6
/ immunology
Male
Mice
Middle Aged
Myocytes, Cardiac
/ metabolism
RNA, Messenger
/ metabolism
Tumor Necrosis Factor-alpha
/ immunology
Young Adult
Gap Junction alpha-5 Protein
P‐wave indices
atrial electrical remodeling
atrial fibrillation
connexins
interleukin‐6
systemic inflammation
Journal
Journal of the American Heart Association
ISSN: 2047-9980
Titre abrégé: J Am Heart Assoc
Pays: England
ID NLM: 101580524
Informations de publication
Date de publication:
20 08 2019
20 08 2019
Historique:
entrez:
20
8
2019
pubmed:
20
8
2019
medline:
11
11
2020
Statut:
ppublish
Résumé
Background Systemic inflammation is a strong predictor of atrial fibrillation. A key role for electrical remodeling is increasingly recognized, and experimental data suggest that inflammatory cytokines can directly affect connexins resulting in gap-junction dysfunction. We hypothesized that systemic inflammation, regardless of its origin, promotes atrial electric remodeling in vivo, as a result of cytokine-mediated changes in connexin expression. Methods and Results Fifty-four patients with different inflammatory diseases and elevated C-reactive protein were prospectively enrolled, and electrocardiographic P-wave dispersion indices, cytokine levels (interleukin-6, tumor necrosis factor-α, interleukin-1, interleukin-10), and connexin expression (connexin 40, connexin 43) were measured during active disease and after reducing C-reactive protein by >75%. Moreover, peripheral blood mononuclear cells and atrial tissue specimens from an additional sample of 12 patients undergoing cardiac surgery were evaluated for atrial and circulating mRNA levels of connexins. Finally, in vitro effects of interleukin-6 on connexin expression were studied in HL-1 mouse atrial myocytes. In patients with active inflammatory diseases, P-wave dispersion indices were increased but rapidly decreased within days when C-reactive protein normalizes and interleukin-6 levels decline. In inflammatory disease patients, both P-wave dispersion indices and interleukin-6 changes were inversely associated with circulating connexin levels, and a positive correlation between connexin expression in peripheral blood mononuclear cells and atrial tissue was demonstrated. Moreover, interleukin-6 significantly reduced connexin expression in HL-1 cells. Conclusions Our data suggest that regardless of specific etiology and organ localization, systemic inflammation, via interleukin-6 elevation, rapidly induces atrial electrical remodeling by down-regulating cardiac connexins. Although transient, these changes may significantly increase the risk for atrial fibrillation and related complications during active inflammatory processes.
Identifiants
pubmed: 31423933
doi: 10.1161/JAHA.118.011006
pmc: PMC6759884
doi:
Substances chimiques
Anti-Bacterial Agents
0
Anti-Inflammatory Agents
0
Connexin 43
0
Connexins
0
GJA1 protein, human
0
GJA1 protein, mouse
0
IL10 protein, human
0
IL6 protein, human
0
Interleukin-1
0
Interleukin-6
0
RNA, Messenger
0
TNF protein, human
0
Tumor Necrosis Factor-alpha
0
Interleukin-10
130068-27-8
C-Reactive Protein
9007-41-4
Types de publication
Journal Article
Research Support, Non-U.S. Gov't
Langues
eng
Sous-ensembles de citation
IM
Pagination
e011006Subventions
Organisme : BLRD VA
ID : I01 BX002137
Pays : United States
Commentaires et corrections
Type : CommentIn
Références
J Am Coll Cardiol. 2012 Dec 4;60(22):2263-70
pubmed: 23194937
Blood. 1990 Jan 1;75(1):40-7
pubmed: 2294996
J Am Heart Assoc. 2016 Aug 19;5(8):
pubmed: 27543307
Int J Med Sci. 2011;8(7):540-6
pubmed: 21960745
Cardiovasc Res. 2004 May 1;62(2):357-67
pubmed: 15094355
Mediators Inflamm. 2013;2013:165974
pubmed: 23853427
Cytokine. 1999 Mar;11(3):216-24
pubmed: 10209069
J Geriatr Cardiol. 2016 Jul;13(5):444-9
pubmed: 27594874
Circulation. 2012 Jan 17;125(2):203-6
pubmed: 22158757
Chest. 1993 Feb;103(2):565-75
pubmed: 8432155
Basic Res Cardiol. 2016 Nov;111(6):63
pubmed: 27660282
J Int Med Res. 2007 Nov-Dec;35(6):796-802
pubmed: 18034993
Europace. 2014 Apr;16(4):477-84
pubmed: 24108228
Pacing Clin Electrophysiol. 1986 Nov;9(6):1095-100
pubmed: 2432515
Ann Noninvasive Electrocardiol. 2010 Oct;15(4):344-52
pubmed: 20946557
J Am Heart Assoc. 2019 Aug 20;8(16):e011006
pubmed: 31423933
Ann Rheum Dis. 2011 Jul;70(7):1208-15
pubmed: 21478189
J Am Coll Cardiol. 2014 Jun 3;63(21):2261-9
pubmed: 24703920
Circ Arrhythm Electrophysiol. 2009 Feb;2(1):72-9
pubmed: 19808445
Ups J Med Sci. 2013 Mar;118(1):35-41
pubmed: 23153368
Eur Heart J. 2012 Aug;33(16):2054-64
pubmed: 21840930
Cardiovasc Res. 2008 Oct 1;80(1):9-19
pubmed: 18519446
Circulation. 2001 May 29;103(21):E111-1
pubmed: 11382743
Am Heart J. 2009 Oct;158(4):622-8
pubmed: 19781423
Eur Rev Med Pharmacol Sci. 2016;20(6):1123-9
pubmed: 27049266
Am J Physiol. 1993 Sep;265(3 Pt 2):R653-8
pubmed: 8214161
Circ Res. 2000 Apr 14;86(7):723-8
pubmed: 10764404
Lancet. 2010 Apr 3;375(9721):1212-23
pubmed: 20334907
Chin Med J (Engl). 2015 Jun 5;128(11):1450-4
pubmed: 26021499
Ann Surg. 2014 Nov;260(5):772-8; discussion 778
pubmed: 25379848
Proc Natl Acad Sci U S A. 1998 Mar 17;95(6):2979-84
pubmed: 9501201
J Am Heart Assoc. 2018 Nov 20;7(22):e010595
pubmed: 30571503
J Immunol. 2011 Sep 15;187(6):3121-32
pubmed: 21844382
Am J Physiol Heart Circ Physiol. 2007 Mar;292(3):H1561-7
pubmed: 17122196
Shock. 2000 Jul;14(1):73-8
pubmed: 10909897
JRSM Cardiovasc Dis. 2016 Mar 21;5:2048004016639443
pubmed: 27081484
Am J Physiol Heart Circ Physiol. 2012 Feb 1;302(3):H790-800
pubmed: 22101526
Arthritis Care Res (Hoboken). 2015 Mar;67(3):332-9
pubmed: 25186226
Ann Transl Med. 2018 Jan;6(1):6
pubmed: 29404352
Eur Heart J. 2017 Jun 7;38(22):1717-1727
pubmed: 27252448
Circulation. 2014 Feb 25;129(8):837-47
pubmed: 24345399
Int J Clin Exp Med. 2014 Nov 15;7(11):4434-40
pubmed: 25550965
Clin Transplant. 2011 Jan-Feb;25(1):119-25
pubmed: 19878513
Nat Rev Immunol. 2019 Jan;19(1):63-64
pubmed: 30552387
Crit Care Med. 1989 Oct;17(10):975-8
pubmed: 2791581
Circ J. 2013;77(5):1171-9
pubmed: 23370453
Curr Opin Cardiol. 2012 May;27(3):236-41
pubmed: 22382502
J Trop Pediatr. 2016 Oct;62(5):377-84
pubmed: 27085180
Int J Rheum Dis. 2017 Apr;20(4):434-441
pubmed: 26692475
Am J Hypertens. 2010 Feb;23(2):202-7
pubmed: 19942863
Nat Rev Cardiol. 2015 Apr;12(4):230-43
pubmed: 25622848
Crit Care. 2010;14(3):R108
pubmed: 20537138
Arthritis Care Res (Hoboken). 2015 Jul;67(7):905-12
pubmed: 25384758
Biomed Res Int. 2015;2015:809514
pubmed: 25815336